Does Antiplatelet Therapy during Bridging Thrombolysis Increase Rates of Intracerebral Hemorrhage in Stroke Patients?

Anne Broeg-MorvayPasquale MordasiniAgnieszka SlezakKai LiesirovaJulia MeisterernstGerhard SchrothMarcel ArnoldSimon JungHeinrich P MattleJan GrallaUrs Fischer

Published in: PloS one (2017)

Antiplatelet therapy before or during bridging thrombolysis in patients with acute ischemic stroke did not increase the risk of bleeding complications and had no impact on outcome. This finding has to be confirmed in larger studies.

Keyphrases

antiplatelet therapy
acute ischemic stroke
acute coronary syndrome
percutaneous coronary intervention
brain injury
atrial fibrillation
risk factors
coronary artery disease
pulmonary embolism
case control